Previous Close | 71.38 |
1-Year Change | -17.06% |
6-Months Change | 17.59% |
3-Months Change | 7.03% |
Moving Avg (50d) | 72.218 |
Moving Avg (200d) | 75.526 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 43.3B |
Beta (3-Years) | 0.93 |
Revenue Growth (ttm) | 8.49% |
Net Profit Margin (ttm) | 24.66% |
Return On Assets (ttm) | 15.31% |
EPS (ttm) | 2.34 |
PE Ratio (ttm) | 30.5 |
Dividend Yield | % |
Asset Description: | Edwards Lifesciences Corporation |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2025-01-28 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
69.952 | 67.811 | 66.383 | 64.242 | 60.673 | 57.104 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.